Institutional filer profile
ARCH Venture Fund IX Overage L.P. Insider Trades
ARCH Venture Fund IX Overage L.P. has reported 1 open-market purchase on SEC Form 4 and is a net buyer of $24,960,152 across 2 companies. The most recent open-market transaction was reported on Nov 4, 2026. Source: SEC Form 4 filings.
Latest reported as Corporate insider of Lyell Immunopharma, Inc. (LYEL).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 1
- Reported companies
- 2
- Net open-market value
- $24,960,152
- Latest transaction
- Nov 4, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
ARCH Venture Fund IX Overage L.P. insider trading FAQ
- Is ARCH Venture Fund IX Overage L.P. buying or selling stock?
- Across all SEC Form 4 open-market filings on record, ARCH Venture Fund IX Overage L.P. is a net buyer of $24,960,152, with 1 open-market purchase reported. The latest transaction was reported on Nov 4, 2026.
- Which companies does ARCH Venture Fund IX Overage L.P. report insider trades for?
- ARCH Venture Fund IX Overage L.P. has reported open-market trades in Lyell Immunopharma, Inc. (LYEL), Boundless Bio, Inc. (BOLD). The latest SEC-reported relationship is Corporate insider of Lyell Immunopharma, Inc. (LYEL).
- Where does ARCH Venture Fund IX Overage L.P.'s insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under filer CIK 1666307, and refreshes this page daily.
